Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- N. Tang, Deng'Ju Li, Xiong Wang, Ziyong Sun
- Medicine, BiologyJournal of Thrombosis and Haemostasis
- 19 February 2020
In the recent outbreak of novel coronavirus infection in Wuhan, China, significantly abnormal coagulation parameters in severe novel coronavirus pneumonia (NCP) cases were a concern.
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
- N. Tang, Huan Bai, Xing Chen, J. Gong, Deng'Ju Li, Ziyong Sun
- MedicineJournal of Thrombosis and Haemostasis
- 27 March 2020
A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of…
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
- Shi-qi Yin, Ming Huang, Deng'Ju Li, N. Tang
- Medicine, BiologyJournal of Thrombosis and Thrombolysis
- 3 April 2020
Patients with severe pneumonia induced by SARS-CoV2 had higher platelet count than those induced by non-SARS- CoV2, and only the former with markedly elevated D-dimer may benefit from anticoagulant treatment.
miR-638 Regulates Differentiation and Proliferation in Leukemic Cells by Targeting Cyclin-dependent Kinase 2*
- Yi Lin, Deng'Ju Li, Zan Huang
- Biology, MedicineJournal of Biological Chemistry
- 1 December 2014
The data suggest that miR-638 regulates proliferation and myeloid differentiation by targeting CDK2 and may serve as a novel target for leukemia therapy or marker for AML diagnosis and prognosis.
c-MYC and reactive oxygen species play roles in tetrandrine-induced leukemia differentiation
- Guixian Wu, Ting Liu, Han Li, Yafang Li, Deng'Ju Li, Wenhua Li
- Chemistry, BiologyCell Death and Disease
- 27 April 2018
The results suggest that ROS generation and c-MYC suppression play important roles in tetrandrine-induced autophagy and differentiation, and the results from in vivo experiments were consistent with those from in vitro studies.
Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models.
- Brandy Pickens, Y. Mao, X. Zheng
- Biology, MedicineBlood
- 21 May 2015
Characterization of transgenic mice expressing recombinant human ADAMTS13 in platelets and its efficacy in inhibiting arterial thrombosis and preventing hereditary and acquired antibody-mediated TTP in murine models provide a proof of concept that platelet-delivered ADAMts13 may be explored as a novel treatment of arterialThrombotic disorders, including hereditary and acquisition TTP.
Effect of serum monoclonal protein concentration on haemostasis in patients with multiple myeloma
- Heyu Huang, Huijun Li, Deng'Ju Li
- Medicine, BiologyBlood Coagulation and Fibrinolysis
- 1 July 2015
Haemostasis screening tests and serum monoclonal protein (M protein) concentration were retrospectively analysed in 101 patients newly diagnosed with multiple myeloma from January 2012 to April 2014 and found prolonged thrombin time was found in most of patients and was positively related to light-chain concentration.
Validation of the PLASMIC score, a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis, in Chinese patients.
- N. Tang, Xiong Wang, Deng'Ju Li, Ziyong Sun
- Medicine, BiologyThrombosis Research
- 1 December 2018
ANP32A regulates histone H3 acetylation and promotes leukemogenesis
- Xuejing Yang, B. Lu, Zan Huang
- BiologyLeukemia
- 2 February 2018
The data indicate that ANP32A is a novel regulator of histone H3 acetylation and promotes leukemogenesis.
Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study
- L. Sheng, Xiong Wang, N. Tang, F. Meng, Liang Huang, Deng'Ju Li
- MedicineClinical and Experimental Medicine (Testo…
- 19 September 2020
Age, comorbidities, platelet count, albumin, D-dimer, LDH, CRP and IL-6 level might be more meaningful marks for COVID-19 prognostic evaluation.
...
...